ICUI — ICU MEDICAL INC/DE

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 883984 ·
Last close
$182.55
Market Cap
$4.57B
52W High
$192.85
52W Low
$129.34
ADV30
317,545
Next earnings
2026-11-05
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 551,683,000 235,053,000 60,429,000 19,087,000 3,971,282,000 298,299,000 1,819,431,000
Mar 2026 530,225,000 206,226,000 30,380,000 30,132,000 4,013,763,000 288,330,000 1,901,835,000
Dec 2025 540,704,000 202,985,000 26,087,000 -15,734,000 4,050,508,000 307,963,000 1,926,683,000
Sep 2025 536,990,000 200,881,000 26,857,000 -3,396,000 4,102,896,000 299,732,000 1,975,646,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$167,402,000
Investing CF
$127,831,000
Financing CF
$-299,311,000
CapEx
$-93,372,000
Dividends Paid
Buybacks
EPS Diluted TTM
$1.85
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$740,109,000
Inventory
$607,421,000
Receivables
$218,635,000
ST Investments
$0
EBIT TTM
$82,854,000
Pretax Income TTM
$754,000
Interest Exp TTM
$82,100,000
Analysts
8

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,159,601,920
EBITDA
$326,124,000
Free Cash Flow
$163,559,632
Enterprise Value
$5,556,807,680
Total Cash
$302,643,008
Total Debt
$1,287,164,032
Shares Out
25,007,038
Trailing EPS
$1.19
Book Value
$86.05
ROE
1.4%
ROA
1.9%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 2,231,262,000 109,334,000 732,000 4,050,508,000 1,926,683,000 179,847,000
Dec 2024 2,382,046,000 97,405,000 -117,688,000 4,203,931,000 2,238,696,000 204,033,000
Dec 2023 2,259,126,000 47,836,000 -29,655,000 4,378,439,000 2,255,029,000 166,201,000
Dec 2022 2,279,997,000 -3,568,000 -74,286,000 4,515,641,000 2,425,713,000 -62,129,000

TTM Snapshot

Revenues TTM
$2,076,359,000
NetIncome TTM
$-63,620,000
OpCashFlow TTM
$0
Assets (Latest)
$4,203,931,000
Forward EPS
$9.65

Max Pain — expiry 2026-11-20

max pain strike: $105.00 · spot: $182.55 · call oi: 3,068 · put oi: 49

Peers — same industry

TickerNameMarket CapLastDaily %
NVST Envista Holdings Corp $4.39B $27.34
HTFL Heartflow, Inc. $4.37B $50.20
LIVN LivaNova PLC $4.31B $78.26
ITGR Integer Holdings Corp $4.25B $125.07
HAE HAEMONETICS CORP $4.93B $108.40

News headlines (Yahoo Finance, 1h cache)

The 5 Most Interesting Analyst Questions From ICU Medical’s Q2 Earnings Call
2026-08-15 03:57 · Yahoo
ICU Medical (ICUI) Q2 2026 Earnings Call Transcript
2026-08-13 23:48 · Yahoo
ICU Medical (ICUI) Stock Gets Fair Value Boost After Analysts Lift Targets
2026-08-09 05:11 · Yahoo
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
2026-08-06 23:30 · Yahoo
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
2026-08-06 23:10 · Yahoo
ICU Medical (NASDAQ:ICUI) Reports Strong Q2 CY2026
2026-08-06 21:14 · Yahoo
1 Small-Cap Stock with Promising Prospects and 2 We Brush Off
2026-08-17 21:26 · Yahoo
ICU Medical, Inc. Q2 2026 Earnings Call Summary
2026-08-07 12:30 · Yahoo
Q2 Earnings Highlights: ICU Medical (NASDAQ:ICUI) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
2026-08-24 18:33 · Yahoo
ICU Medical (ICUI): Buy, Sell, or Hold Post Q2 Earnings?
2026-08-17 14:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.